Stock DNA
Pharmaceuticals & Biotechnology
SAR 10,857 Million (Small Cap)
21.00
NA
0.00%
-0.10
27.03%
6.32
Revenue and Profits:
Net Sales:
305 Million
(Quarterly Results - Dec 2025)
Net Profit:
68 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.96%
0%
-6.96%
6 Months
1.84%
0%
1.84%
1 Year
13.97%
0%
13.97%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Jamjoom Pharmaceuticals Factory Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
16.76%
EBIT Growth (5y)
22.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.85
Tax Ratio
5.60%
Dividend Payout Ratio
60.61%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.93%
ROE (avg)
21.80%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
5.79
EV to EBIT
21.16
EV to EBITDA
19.80
EV to Capital Employed
5.79
EV to Sales
6.62
PEG Ratio
0.75
Dividend Yield
NA
ROCE (Latest)
27.37%
ROE (Latest)
27.03%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
304.60
259.70
17.29%
Operating Profit (PBDIT) excl Other Income
71.30
64.40
10.71%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
-2.20
100.00%
Consolidate Net Profit
68.10
51.60
31.98%
Operating Profit Margin (Excl OI)
234.10%
208.60%
2.55%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is 17.29% vs 24.92% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 31.98% vs 15.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,500.60
1,318.50
13.81%
Operating Profit (PBDIT) excl Other Income
474.80
418.00
13.59%
Interest
0.00
0.70
-100.00%
Exceptional Items
0.00
-10.30
100.00%
Consolidate Net Profit
463.80
356.50
30.10%
Operating Profit Margin (Excl OI)
316.40%
288.60%
2.78%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 13.81% vs 19.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 30.10% vs 21.92% in Dec 2024
About Jamjoom Pharmaceuticals Factory Co. 
Jamjoom Pharmaceuticals Factory Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






